Oda Stoevesandt Selected Research

cytohesin-1

1/2021

CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oda Stoevesandt Research Topics

Disease

4	Metrorrhagia (Spotting) 01/2011 - 02/2008
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2021 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2020
2	Neoplasms (Cancer) 06/2012 - 01/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	T-Cell Leukemia (Leukemia, T Cell) 03/2015

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2008
4	AutoantibodiesIBA 01/2021 - 02/2020
3	ProteomeIBA 01/2021 - 01/2010
2	AntigensIBA 01/2021 - 01/2010
2	AutoantigensIBA 01/2021 - 02/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2020
2	AntibodiesIBA 01/2021 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 04/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	M-cadherinIBA 01/2021
1	radixinIBA 01/2021
1	cytohesin-1IBA 01/2021
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 01/2021
1	ezrinIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 06/2012
1	Peptides (Polypeptides)IBA 01/2010
1	Indicators and Reagents (Reagents)IBA 01/2010